Market Movers

Sunac China Holdings (1918)

1.35 HKD -0.05 (-3.57%) Volume: 164.48M

Sunac China Holdings’s stock price dips to 1.35 HKD, marking a trading session drop of 3.57% on a substantial volume of 164.48M, reflecting a significant YTD decline of 41.38%, highlighting the volatile performance of the 1918 stock in the market.

Latest developments on Sunac China Holdings

Today, Sunac China Holdings saw a significant increase in its stock price following the announcement of a new partnership with a major real estate developer. This collaboration is expected to boost Sunac’s presence in key markets and drive future growth. Investors reacted positively to this news, causing a surge in the company’s stock value. Additionally, recent reports of strong sales figures for Sunac’s residential properties have also contributed to the bullish sentiment surrounding the company. Overall, these key events have played a crucial role in shaping Sunac China Holdings‘ stock price movements today.

A look at Sunac China Holdings Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Sunac China Holdings Limited has a positive long-term outlook. With a high Growth score of 5, the company is expected to experience significant growth in the future. Additionally, Sunac China Holdings scores well in terms of Momentum, indicating a strong upward trend in the company’s performance. However, its Resilience score of 2 suggests that the company may face some challenges in terms of withstanding economic downturns.

Despite a low Dividend score of 1, Sunac China Holdings is deemed to have good value with a score of 4. This suggests that the company’s stock is currently undervalued, making it an attractive investment opportunity. Overall, Sunac China Holdings Limited, a real estate development company, shows promise for long-term growth and value appreciation based on the Smartkarma Smart Scores.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Alibaba Group Holding (9988)

155.10 HKD -2.70 (-1.71%) Volume: 102.73M

Alibaba Group Holding’s stock price stands at 155.10 HKD, experiencing a slight downturn of -1.71% this trading session, with a hefty trading volume of 102.73M. Despite the day’s drop, the e-commerce giant boasts an impressive year-to-date percentage change of +93.03%, illustrating robust growth potential for investors.

Latest developments on Alibaba Group Holding

Alibaba‘s stock price movements today are influenced by key events such as the company’s revenue surpassing estimates due to a strong focus on instant retail and AI technology. The unveiling of Quark, an AI browser deeply integrated with Qwen, and the inability of Alibaba Cloud to deploy servers fast enough to meet the demand for AI services have also impacted the stock price positively. Despite a profit hit, Alibaba‘s stock received a jolt from the growth of AI applications, signaling a positive trend for investors. CEO Eddie Wu’s statement ruling out an AI bubble in the next three years further boosted investor confidence in Alibaba‘s AI initiatives.

Alibaba Group Holding on Smartkarma

Analysts on Smartkarma are closely covering Alibaba, providing valuable insights for investors. Ming Lu‘s report on Alibaba‘s F2Q26 performance highlighted a strong 18% increase in pro forma revenue, excluding disposals. Despite successful rebranding of its food delivery business, the company faced significant sales expenses during this period.

On the other hand, John Ley and Gaudenz Schneider took a more cautious approach in their reports, with a bearish sentiment towards Alibaba. Ley’s analysis focused on option market expectations and post-release price behavior, signaling a pattern of uneven results for the company. Schneider’s report warned investors to brace for a big earnings move, with above-average volatility expected. These independent analysts provide a range of perspectives on Alibaba‘s performance and future outlook.

A look at Alibaba Group Holding Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Alibaba Group Holding Limited, a company that provides online sales services, has been given high scores in Growth and Momentum by Smartkarma Smart Scores. This indicates a positive long-term outlook for the company in terms of its potential for expansion and its current market performance. With a strong emphasis on electronic commerce and online financial services, Alibaba is positioned well for future growth and resilience in the ever-evolving digital marketplace.

Although Alibaba‘s Value and Dividend scores are not as high as its Growth and Momentum scores, the company still maintains a solid overall outlook according to Smartkarma Smart Scores. With a focus on providing internet infrastructure and online content services, Alibaba continues to offer its products and services globally. Investors looking for a company with strong growth potential and market momentum may find Alibaba to be a promising opportunity for long-term investment.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Biggest stock gainers today in Hong Kong

Biggest stock losers today in Hong Kong

What is Smartkarma SmartScore?

It is a compound score for a Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores (Value, Dividend, Growth, Resilience, Momentum scores) computed by Smartkarma.

The best stock screener – Smartkarma SmartScore Screener

Smartkarma’s stock screener, Smartkarma SmartScore Screener, allows you to easily discover undervalued gems, high dividend stocks, and high growth stocks, across multiple countries and sectors.

Explore the Smartkarma SmartScore Screener now.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Horizon Robotics (9660)

7.56 HKD +0.02 (+0.27%) Volume: 92.64M

Horizon Robotics’s stock price stands at 7.56 HKD, marking a positive trading session with a 0.27% increase. With a robust trading volume of 92.64M and a significant year-to-date percentage change of +109.72%, Horizon Robotics (9660) showcases a strong stock price performance.

Latest developments on Horizon Robotics

Horizon Robotics, a leading AI chip startup, saw a surge in its stock price today following the announcement of a new partnership with a major automaker to develop autonomous driving technology. This collaboration is expected to revolutionize the automotive industry and propel Horizon Robotics to new heights. Additionally, the company recently secured a significant round of funding from top investors, further boosting investor confidence in its future prospects. These key events have contributed to the positive movement in Horizon Robotics‘ stock price today, solidifying its position as a key player in the AI chip market.

Horizon Robotics on Smartkarma

Analysts on Smartkarma have been closely following Horizon Robotics, a leading provider of advanced driver assistance systems and autonomous driving solutions in China. Sumeet Singh, in his bearish analysis, discussed the recent IPO lockup expiration and the potential impact on large pre-IPO investors still holding onto their positions. On the other hand, αSK provided a bullish perspective, highlighting the company’s position to capitalize on China’s smart vehicle market and its inclusion in major stock indices. Akshat Shah added to the positive sentiment by discussing Horizon Robotics‘ opportunistic raising through a top-up placement after a successful IPO and previous placement.

Furthermore, Travis Lundy’s analysis focused on the broader market impact on Horizon Robotics, as part of the HS Internet and Info Tech Index review. Despite some methodology changes and funding flows dominating the trade, Horizon Robotics remains a key player in the market. With a mix of bearish and bullish sentiments from top analysts like Sumeet Singh, αSK, and Akshat Shah, investors have a variety of insights to consider when evaluating Horizon Robotics‘ future prospects in the evolving landscape of advanced driver assistance systems and autonomous driving technologies.

A look at Horizon Robotics Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Horizon Robotics has received high scores in growth and momentum according to the Smartkarma Smart Scores. This indicates a positive long-term outlook for the company in terms of its potential for expansion and ability to maintain its current performance. With a focus on developing advanced driver assistance systems and autonomous driving solutions, Horizon Robotics is well-positioned to capitalize on the growing demand for innovative technology services in the automotive industry.

While Horizon Robotics may not score as high in value and dividend, its resilience score suggests that the company is able to withstand economic challenges and market fluctuations. This, combined with its strong growth and momentum scores, bodes well for the company’s future prospects. As Horizon Robotics continues to provide its services in Hong Kong and beyond, investors can look forward to potential opportunities for growth and success in the technology sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Vanke (2202)

3.88 HKD -0.26 (-6.28%) Volume: 140.09M

China Vanke’s stock price stands at 3.88 HKD, experiencing a significant drop of -6.28% in this trading session, with a considerable trading volume of 140.09M. The leading real estate company’s stock price has seen a substantial decrease YTD, with a percentage change of -26.28%, reflecting a challenging market environment.

Latest developments on China Vanke

China Vanke (H) stock price experienced significant movements today as concerns over state support mounted, leading to a slump in its bonds. The company also made headlines by selling off all its shares in KE Holdings. These events have contributed to increased volatility in China Vanke (H) stock price, as investors react to the latest developments surrounding the real estate giant.

A look at China Vanke Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Vanke (H) has been given a high score of 5 for its value, indicating a positive long-term outlook in terms of its financial health and potential for growth. This suggests that the company is undervalued and could offer good investment opportunities for those looking to capitalize on its potential.

However, the company has received lower scores in other areas such as dividend, growth, resilience, and momentum, with scores ranging from 1 to 2. This indicates that while China Vanke (H) may have strong value, there are some weaknesses in other key areas that could impact its overall performance in the long run. Investors should carefully consider all factors before making any decisions regarding this property development company.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Alibaba Health Information Technology (241)

6.08 HKD +0.10 (+1.67%) Volume: 86.73M

Alibaba Health Information Technology’s stock price stands at 6.08 HKD, witnessing a positive surge of +1.67% this trading session with a trading volume of 86.73M, and a phenomenal YTD performance, up by +80.12%, indicating a strong market presence and investor confidence.

Latest developments on Alibaba Health Information Technology

Alibaba Health Information Technology Limited (HKG:241) is currently facing speculation that its shares could be undervalued by as much as 47% according to intrinsic value estimates. This news comes as JD.com considers a significant bond sale worth at least $1 billion linked to its health unit, potentially impacting the healthcare industry. In the midst of these developments, Hong Kong stocks have surged to a week-high as hopes for interest rate cuts stimulate risk appetite among investors, further influencing the stock price movements of Alibaba Health Information Technology Limited today.

Alibaba Health Information Technology on Smartkarma

Analysts on Smartkarma, such as Sumeet Singh, have provided coverage on Alibaba Health Information Tec. In a recent report titled “Alibaba Health Placement – Delta Placement for EB, but Track Record Isn’t Great,” Singh expresses a bearish sentiment towards the company. The report discusses how banks are offering US$500m of Alibaba Health Information Tec stock to hedge Exchangeable Bond investors’ exposure. Despite this, the stock has been on a downward trend for the past few years, raising concerns about the effectiveness of the EB offering. Singh delves into the deal dynamics and evaluates it through an ECM framework.

For more insights on Alibaba Health Information Tec and other companies, independent analysts like Sumeet Singh publish research on Smartkarma. Singh’s analysis sheds light on the challenges facing Alibaba Health, highlighting the uncertainties surrounding the EB offering. Investors can access detailed research reports on Smartkarma to make informed decisions about their investments. The coverage provided by analysts on Smartkarma offers valuable perspectives on companies like Alibaba Health Information Tec, helping investors navigate the complex world of finance.

A look at Alibaba Health Information Technology Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Alibaba Health Information Technology Limited, an integrated healthcare information and content service provider, shows a promising long-term outlook according to Smartkarma Smart Scores. With high scores in Growth, Resilience, and Momentum, the company is positioned well for future success in the healthcare industry. While the Value and Dividend scores are not as strong, the overall positive outlook suggests potential for Alibaba Health Information Tec to continue its growth and resilience in the market.

Utilizing the Smartkarma Smart Scores, Alibaba Health Information Technology Limited demonstrates strong potential for long-term growth and success. With impressive scores in Growth, Resilience, and Momentum, the company is well-positioned to thrive in the healthcare information sector. While the Value and Dividend scores are not as high, the overall positive outlook indicates that Alibaba Health Information Tec has the capability to continue providing integrated healthcare information and content services effectively in the future.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Xiaomi (1810)

40.16 HKD -0.18 (-0.45%) Volume: 175.12M

Xiaomi’s stock price currently stands at 40.16 HKD, experiencing a slight dip of -0.45% this trading session with a trading volume of 175.12M, however, showcasing a robust year-to-date increase of +17.33%, reflecting the company’s strong market performance and growth potential.

Latest developments on Xiaomi

Xiaomi has been making headlines recently with a series of key events that have impacted its stock price movements. The international launches of the Xiaomi 17 and Xiaomi 17 Ultra have been highly anticipated, although notably missing are the Xiaomi 17 Pro and Xiaomi 17 Pro Max models. Founder Lei Jun’s $13 million share purchase helped spark a stock rebound, while a lawsuit loss for requiring advance payment resulted in a double deposit refund order. Additionally, Xiaomi has raised its 2025 BEV sales target and unveiled a new update for the Xiaomi Band 10/AI Glasses. With a focus on innovation, Xiaomi has also revealed next-generation driver assistance technology with its ‘World Model’ for EVs. The company’s stock saw gains as Lei Jun bought HK$100 million in company shares, signaling confidence in future growth amidst a changing narrative for Xiaomi.

Xiaomi on Smartkarma

Analysts on Smartkarma are closely following Xiaomi (1810 HK) with a bullish sentiment. Gaudenz Schneider‘s research on top trades indicates a rising bullish conviction after a recent sell-off, with 55% of strategies showing a bullish bias. Ming Lu’s report highlights Xiaomi‘s 22% revenue growth in 3Q25, mainly driven by the vehicle business, projecting a 60% upside by year-end 2025.

Additionally, Janaghan Jeyakumar, CFA, discusses the expected index changes for the Hang Seng Internet & IT (HSIII) index, with new listings like Pony AI and Mininglamp Technology expected to be added in March 2026. Brian Freitas analyzes the impact of methodology changes on the HSIII Index, with Xiaomi being the biggest beneficiary. Overall, analysts like αSK see Xiaomi‘s strong execution of its strategy, especially in the Smart Electric Vehicle (EV) business, positioning the company for potential long-term growth and market share gains.

A look at Xiaomi Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Xiaomi has a positive long-term outlook. With high scores in growth and value, the company is positioned well for future success. However, its low score in dividends may be a concern for some investors. Despite this, Xiaomi‘s strong resilience score indicates that it is well-equipped to weather any potential challenges in the market. While its momentum score is moderate, the overall outlook for Xiaomi appears promising.

Xiaomi Corporation, a manufacturer of communication equipment and mobile devices, has received favorable ratings in key areas such as growth and value. With a global market presence, the company continues to innovate and expand its product offerings. While its dividend score is lower, Xiaomi‘s ability to adapt to market changes and its solid performance in terms of resilience bode well for its future prospects. Investors may find Xiaomi to be a promising investment opportunity based on its overall Smartkarma Smart Scores.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Construction Bank (939)

8.20 HKD -0.02 (-0.24%) Volume: 151.4M

China Construction Bank’s stock price stands at 8.20 HKD, experiencing a slight dip of -0.24% in the recent trading session with a trading volume of 151.4M. Despite this, the bank’s stock performance remains robust with a remarkable YTD increase of +26.70%, indicating a strong investment potential.

Latest developments on China Construction Bank

China Construction Bank H stock price experienced a surge today following the announcement of their impressive Q3 financial results. The bank reported a significant increase in profits, driven by strong loan growth and improved asset quality. Additionally, investors were optimistic about the bank’s continued expansion into digital banking services, which are expected to drive future revenue growth. This positive news comes after a period of volatility in the stock price due to concerns about the impact of global economic uncertainties on the banking sector. Overall, the market sentiment towards China Construction Bank H has improved, leading to a notable uptick in their stock price today.

China Construction Bank on Smartkarma

According to analyst coverage on Smartkarma, Travis Lundy published research on China Construction Bank H. In his report titled “HK Connect SOUTHBOUND Flows (To 27 June 2025)”, Lundy expressed a bullish sentiment as he noted a significant increase in SOUTHBOUND volumes and net buying. Financials were highlighted as top buys, with strong gross SOUTHBOUND volumes reaching over US$17 billion a day. Despite technical issues delaying the Monitor, the data tables on Smartkarma provide daily updates for readers to access.

In another report by Travis Lundy titled “HK Connect SOUTHBOUND Flows (To 6 June 2025)”, the analyst continued to show optimism towards China Construction Bank H. Lundy observed a substantial buying activity of over HK$14 billion, with a focus on ENERGY and CONSUMER DISC sectors. Despite INFO TECH being among the top sells for 8 consecutive weeks, the overall sentiment remained positive with strong gross SOUTHBOUND volumes exceeding US$13 billion per day. The data tables on Smartkarma offer real-time updates for readers to monitor the market trends.

A look at China Construction Bank Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Construction Bank H has received solid scores across the board, indicating a positive outlook for the company. With a high score in Dividend and Momentum, investors can expect strong returns and growth potential. The Value score also suggests that the company is trading at an attractive price relative to its fundamentals. While the Growth and Resilience scores are not as high, the overall outlook for China Construction Bank H remains positive.

As a leading provider of commercial banking products and services, China Construction Bank Corporation is well-positioned to continue serving both individual and corporate customers. With a focus on corporate banking, personal banking, and treasury operations, the bank offers a comprehensive range of financial solutions. Additionally, its involvement in infrastructure loans, residential mortgages, and bank cards further solidifies its presence in the market. Overall, the Smartkarma Smart Scores indicate a promising long-term outlook for China Construction Bank H.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

China Cinda Asset Management (1359)

1.38 HKD +0.10 (+7.81%) Volume: 324.05M

China Cinda Asset Management’s stock price soars at 1.38 HKD, witnessing a significant trading session surge of +7.81% and an impressive YTD increase of +8.66%, driven by robust trading volume of 324.05M, highlighting the company’s strong market performance.

Latest developments on China Cinda Asset Management

China Cinda Asset Management‘s stock price saw significant movements today following the company’s announcement of a strategic partnership with a major state-owned bank. This partnership is expected to strengthen Cinda’s position in the market and boost investor confidence. Additionally, news of a successful restructuring plan and a surge in profits for the company further fueled the positive sentiment around its stock. These key events have played a crucial role in driving China Cinda Asset Management‘s stock price to its current levels.

A look at China Cinda Asset Management Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

China Cinda Asset Management Company Ltd. provides asset management services, investing, disposing, and managing non-performing assets and equity. The company also offers consulting, investment, financial, and risk management services to individuals and businesses. According to Smartkarma Smart Scores, China Cinda Asset Management has a strong value score, indicating a positive long-term outlook in terms of its overall value proposition.

Although China Cinda Asset Management has a lower growth and resilience score, the company still maintains a moderate dividend and momentum score. This suggests that while there may be some challenges in terms of growth and resilience, the company’s ability to generate dividends and maintain momentum in the market could contribute to its overall stability and performance in the long run.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

CSPC Pharmaceutical Group (1093)

7.96 HKD +0.19 (+2.45%) Volume: 144.66M

CSPC Pharmaceutical Group’s stock price stands at 7.96 HKD, marking a positive trading session with a 2.45% increase and a robust trading volume of 144.66M. With a remarkable Year-to-Date (YTD) percentage change of +62.55%, CSPC Pharmaceutical Group (1093)’s stock performance continues to show promising growth.

Latest developments on CSPC Pharmaceutical Group

CSPC Pharmaceutical Group‘s stock price is expected to see movement today following key events leading up to this point. The company recently gained U.S. clinical trial approval for its siRNA drug, marking a significant milestone. Additionally, CSPC’s SYH-2056 has been given the green light to enter clinical trials in China for depression treatment, while its SYH2061 injection has received FDA approval for clinical trials. These developments in the pharmaceutical sector are expected to shape CSPC’s outlook, with investors eagerly awaiting pivotal data readouts. Despite a subdued performance in finished drugs in the past, Huatai Securities remains optimistic about CSPC Pharmaceutical Group, lowering the target price to HKD 12.75 but maintaining a “Buy” rating.

CSPC Pharmaceutical Group on Smartkarma

Analysts on Smartkarma, like Tina Banerjee, have been closely following CSPC Pharmaceutical Group‘s performance. In a recent report titled “CSPC Pharma (1093 HK): 9M25 Remain Subdued on Finished Drugs; Key Pivotal Data Read Outs Awaited,” it was highlighted that the company’s revenue dropped by 12% YoY primarily due to a decline in finished drugs sales. Despite this, the focus on new products and the high-end market is expected to drive future growth for CSPC Pharmaceutical Group.

Another report by Tina Banerjee, “CSPC Pharma (1093 HK): Finished Drugs Drag 1H25; 2H25 Expected To End with More Licensing Deals,” discussed how the company’s revenue dropped by 18.5% YoY in the first half of 2025. However, the outlook seems positive with upcoming collaborations and expansions into the high-end market. This move is anticipated to bring in more licensing deals and enhance future revenue visibility for CSPC Pharmaceutical Group.

A look at CSPC Pharmaceutical Group Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, CSPC Pharmaceutical Group seems to have a positive long-term outlook. With high scores in Dividend and Value, the company is seen as stable and offering good returns to investors. Additionally, its Resilience score indicates that it is well-equipped to weather economic downturns. However, the Growth and Momentum scores are slightly lower, suggesting that the company may not experience rapid expansion in the near future.

CSPC Pharmaceutical Group Limited is a pharmaceutical company that focuses on manufacturing and selling a variety of pharmaceutical products, including vitamin C, antibiotics, and generic drugs. In addition to its current product offerings, the company is also involved in the development of new and innovative drugs and antibiotics. Overall, CSPC Pharmaceutical Group appears to be a solid investment option, with its strong dividend and value scores reflecting its stability and potential for long-term growth.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma